SP
Therapeutic Areas
Recordati Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Cushing's Disease Portfolio | Cushing's Disease | Commercial |
| Acromegaly Treatments | Acromegaly | Commercial |
| Porphyria Therapies | Porphyria | Commercial |
| Neuroblastoma Treatment | High-risk Neuroblastoma | Commercial |
| Cardiovascular Portfolio | Heart Conditions | Commercial |
| Urology Products | Prostate Cancer/Conditions | Commercial |
Leadership Team at Recordati
RK
Robert Koremans
Chief Executive Officer
MM
Mike McClellan
Chief Financial Officer
AM
Alberto Martinez
Executive VP Specialty & Primary Care Business Unit
SP
Scott Pescatore
Executive VP Rare Diseases Business Unit
MZ
Milan Zdravkovic
Executive VP Research & Development and Chief Medical Officer
BB
Bibianne Bon
Group Chief Legal Officer
AA
Alessandra Abate
Group Chief People and Culture Officer
GF
Gabriele Finzi
Executive VP Corporate Development, Licensing & Innovation
AG
Alessandro Gilio
Executive VP Group Industrial Operations
LC
Laura Conti
Group Communications Director